EU trade with US hits record despite tariff tensions, study shows

EU–U.S. goods trade hit a record €875B in 2024 (+7.7% EU exports; +2.2% U.S. imports), but the report warns tariffs are already damaging specific sectors. EU car and parts exports to the U.S. fell 20.4% in 2025, with Germany down 18.9%, while Ireland rose 52.7% on tariff-exempt pharma/chem exports. Transatlantic services hit €865B, yet the EU ran a €178B services deficit, and IP-related fees (software, patents, trademarks) drove 13.7% growth in U.S. service imports.

Analysis

The important signal is not the aggregate trade number but the widening dispersion inside it. Tariffs are acting like a tax on high-value, high-cross-border-content sectors, so the pain shows up first in autos and parts rather than in broad trade flows. That means the first-order beneficiaries are not “Europe” or “the U.S.” broadly, but U.S.-based IP owners, software licensors, and tariff-exempt pharma/chemicals with pricing power and cleaner trade treatment; the losers are German OEMs and their supplier base, where weaker U.S. access can cascade into lower utilization, worse mix, and higher warranty/overhead leverage over the next 1-3 quarters.

Second-order, this is a supply-chain reordering story. If EU auto exports keep sliding, the marginal gains likely accrue to North American production footprints and non-EU assemblers with U.S. capacity, while European Tier 1s face a double hit: lost unit volume plus weaker bargaining power on contracts. The Ireland divergence matters because it highlights how exemptions can redirect capital and tax structures rather than restore true trade balance; that supports Irish-listed pharma/chemicals and U.S. multinationals using Ireland as a conduit, while making the broader EU headline less informative than sector-level flows.

The contrarian view is that the market may be over-reading nominal trade records as resilience. A record value can still mask unit erosion if prices, front-loading, or mix shift are doing the heavy lifting. The real falsifier for the bearish Europe-auto view is not the next trade print but a 1-2 quarter stabilization in German auto export volumes and margin guidance; absent that, the trend likely persists for 6-18 months as procurement, sourcing, and final assembly re-route around tariffs and exemptions.

Key Decisions for Investors

• Short European autos on relative weakness: use BMWYY/VWAGY/MBGYY or a European autos basket against a long U.S. industrials/parts proxy for 1-3 months; thesis is utilization and mix pressure, with upside if U.S. demand holds but EU export exposure keeps compressing margins.
• Long U.S. IP/software exporters on tariff pass-through: initiate a basket long in XLK/IGV versus EU cyclicals, since rising IP/service fees are a cleaner beneficiary than goods exporters; best held 3-6 months if services trade continues to outgrow goods.
• Overweight Ireland-exposed pharma/chemicals rather than broad Europe: selective longs in large-cap multinational pharma with meaningful Ireland footprint; the edge is exemption-driven volume reallocation, but size modestly because the trade data may already be partially reflected.
• Set a watchlist trigger on German auto export volumes and OEM guidance: if the next quarterly export print fails to stabilize, press the short; if export declines narrow materially, cover 30-50% as the market may have already discounted the tariff hit.
• If you need a low-conviction expression, prefer a pairs trade over outright beta: short EU autos / long U.S. software or U.S. industrials with U.S. domestic revenue, since the mechanism is relative margin resilience rather than a macro growth call.